Literature DB >> 15804665

VTEC O117:K1:H7. A new clonal group of E. coli associated with persistent diarrhoea in Danish travellers.

Bente Olesen1, Charlotte Jensen, Katharina Olsen, Vivian Fussing, Peter Gerner-Smidt, Flemming Scheutz.   

Abstract

20 patients were infected with a new group of verocytotoxin-producing E. coli (VTEC) strains of serotype O117:K1:H7 during a 5-y period. The main symptoms were persistent watery diarrhoea with abdominal cramps; 2 persons of the 20 were healthy carriers. The duration of gastrointestinal symptoms in patients was median 11 weeks with 80% being ill for more than 30 d. In 19 cases the infection was acquired during travel (Asia, Africa and Cuba), and 1 case was laboratory acquired. All strains were positive for the vtx1 gene and negative for the vtx2, the eae, the saa and the ehxA genes. 13 strains (65%) were resistant to 4 or more antimicrobial agents. By PFGE using the restriction enzyme XbaI, the strains were clonally related, but not identical. O117:K1:H7 is a clonal group of VTEC that should be considered in patients returning from Africa and Asia with long-lasting watery diarrhoea.

Entities:  

Mesh:

Year:  2005        PMID: 15804665     DOI: 10.1080/00365540410021090

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  8 in total

1.  Escherichia coli K1-specific bacteriophage CUS-3 distribution and function in phase-variable capsular polysialic acid O acetylation.

Authors:  Michael R King; Ross P Vimr; Susan M Steenbergen; Lodewijk Spanjaard; Guy Plunkett; Frederick R Blattner; Eric R Vimr
Journal:  J Bacteriol       Date:  2007-06-29       Impact factor: 3.490

2.  Human infections with non-O157 Shiga toxin-producing Escherichia coli, Switzerland, 2000-2009.

Authors:  Ursula Käppeli; Herbert Hächler; Nicole Giezendanner; Lothar Beutin; Roger Stephan
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

Review 3.  Review: chronic and persistent diarrhea with a focus in the returning traveler.

Authors:  Christopher A Duplessis; Ramiro L Gutierrez; Chad K Porter
Journal:  Trop Dis Travel Med Vaccines       Date:  2017-05-04

4.  Development of a real-time PCR assay and comparison to CHROMagarTM STEC to screen for Shiga toxin-producing Escherichia coli in stool, Cape Town, South Africa.

Authors:  John B Kalule; Karen H Keddy; Anthony Smith; Mark P Nicol; Lourens Robberts
Journal:  Afr J Lab Med       Date:  2017-12-14

5.  Neuroinvasive Infection from O117:K52:H-Escherichia coli following Acute Pyelonephritis.

Authors:  H Cromlin; H Rodriguez-Villalobos; A Deplano; T Duprez; P Hantson
Journal:  Case Rep Infect Dis       Date:  2017-11-26

6.  An outbreak of a rare Shiga-toxin-producing Escherichia coli serotype (O117:H7) among men who have sex with men.

Authors:  Kate S Baker; Timothy J Dallman; Nicholas R Thomson; Claire Jenkins
Journal:  Microb Genom       Date:  2018-05-21

Review 7.  Travel-Related Antimicrobial Resistance: A Systematic Review.

Authors:  Hamid Bokhary; Krisna N A Pangesti; Harunor Rashid; Moataz Abd El Ghany; Grant A Hill-Cawthorne
Journal:  Trop Med Infect Dis       Date:  2021-01-16

8.  Whole genome sequencing of an unusual serotype of Shiga toxin-producing Escherichia coli.

Authors:  Tim Dallman; Lisa Cross; Chloe Bishop; Neil Perry; Bente Olesen; Kathie A Grant; Claire Jenkins
Journal:  Emerg Infect Dis       Date:  2013-08       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.